Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Working Capital to Net Assets Ratio
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Working Capital to Net Assets ratio of -12.9% as of June 2026. Working capital of CN¥-430.85 Million (current assets of CN¥3.48 Billion minus current liabilities of CN¥3.92 Billion) is measured against net assets of CN¥3.34 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Fujian Aonong Biological Technology Group Incorporation Ltd Working Capital to Net Assets (2013–2025)
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at -12.9%, reflecting working capital of CN¥-430.85 Million against net assets of CN¥3.34 Billion CNY. See operational self-sufficiency of Fujian Aonong Biological Technology Grou to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 603363 total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -6.5% | CN¥-234.01 Million | CN¥3.58 Billion | CN¥3.33 Billion | CN¥3.57 Billion | ▲ +23.4 pp |
| 2024 | -29.9% | CN¥-914.89 Million | CN¥3.06 Billion | CN¥3.70 Billion | CN¥4.61 Billion | ▼ -1733.0 pp |
| 2023 | 1703.1% | CN¥-8.57 Billion | CN¥-503.22 Million | CN¥2.79 Billion | CN¥11.36 Billion | ▲ +1893.4 pp |
| 2022 | -190.3% | CN¥-6.53 Billion | CN¥3.43 Billion | CN¥5.12 Billion | CN¥11.65 Billion | ▲ +76.7 pp |
| 2021 | -266.9% | CN¥-5.85 Billion | CN¥2.19 Billion | CN¥4.26 Billion | CN¥10.12 Billion | ▼ -197.1 pp |
| 2020 | -69.8% | CN¥-2.72 Billion | CN¥3.90 Billion | CN¥3.52 Billion | CN¥6.25 Billion | ▲ +75.7 pp |
| 2019 | -145.5% | CN¥-1.87 Billion | CN¥1.28 Billion | CN¥1.51 Billion | CN¥3.38 Billion | ▼ -70.6 pp |
| 2018 | -74.9% | CN¥-755.55 Million | CN¥1.01 Billion | CN¥1.23 Billion | CN¥1.98 Billion | ▼ -69.6 pp |
| 2017 | -5.2% | CN¥-50.64 Million | CN¥965.55 Million | CN¥1.18 Billion | CN¥1.23 Billion | ▲ +19.9 pp |
| 2016 | -25.2% | CN¥-149.39 Million | CN¥593.75 Million | CN¥801.71 Million | CN¥951.10 Million | ▲ +1.8 pp |
| 2015 | -27.0% | CN¥-120.24 Million | CN¥445.39 Million | CN¥751.31 Million | CN¥871.56 Million | ▲ +39.7 pp |
| 2014 | -66.7% | CN¥-143.45 Million | CN¥214.94 Million | CN¥554.69 Million | CN¥698.14 Million | ▲ +29.0 pp |
| 2013 | -95.8% | CN¥-101.85 Million | CN¥106.35 Million | CN¥502.24 Million | CN¥604.09 Million | — |